293 related articles for article (PubMed ID: 24073010)
21. β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.
Miele E; Po A; Begalli F; Antonucci L; Mastronuzzi A; Marras CE; Carai A; Cucchi D; Abballe L; Besharat ZM; Catanzaro G; Infante P; Di Marcotullio L; Canettieri G; De Smaele E; Screpanti I; Locatelli F; Ferretti E
BMC Cancer; 2017 Jul; 17(1):488. PubMed ID: 28716052
[TBL] [Abstract][Full Text] [Related]
22. Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
Wan XY; Zhai XF; Jiang YP; Han T; Zhang QY; Xin HL
Am J Transl Res; 2017; 9(1):155-166. PubMed ID: 28123642
[TBL] [Abstract][Full Text] [Related]
23. Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.
Zhang L; Ji Q; Liu X; Chen X; Chen Z; Qiu Y; Sun J; Cai J; Zhu H; Li Q
Cancer Sci; 2013 May; 104(5):604-10. PubMed ID: 23363445
[TBL] [Abstract][Full Text] [Related]
24. Novel therapeutic strategies for targeting liver cancer stem cells.
Oishi N; Wang XW
Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
[TBL] [Abstract][Full Text] [Related]
25. Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment.
Kilmister EJ; Koh SP; Weth FR; Gray C; Tan ST
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428556
[TBL] [Abstract][Full Text] [Related]
26. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
27. Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization.
Hong KO; Ahn CH; Yang IH; Han JM; Shin JA; Cho SD; Hong SD
Molecules; 2019 May; 24(10):. PubMed ID: 31109130
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system.
Chi J; Jiang Z; Qiao J; Peng Y; Liu W; Han B
Carbohydr Polym; 2019 Jun; 214():80-89. PubMed ID: 30926011
[TBL] [Abstract][Full Text] [Related]
30. ABC transporters in CSCs membranes as a novel target for treating tumor relapse.
Zinzi L; Contino M; Cantore M; Capparelli E; Leopoldo M; Colabufo NA
Front Pharmacol; 2014; 5():163. PubMed ID: 25071581
[TBL] [Abstract][Full Text] [Related]
31. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin.
Shou LM; Zhang QY; Li W; Xie X; Chen K; Lian L; Li ZY; Gong FR; Dai KS; Mao YX; Tao M
Oncol Rep; 2013 Sep; 30(3):1059-66. PubMed ID: 23835679
[TBL] [Abstract][Full Text] [Related]
32. Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.
Zheng LC; Yang MD; Kuo CL; Lin CH; Fan MJ; Chou YC; Lu HF; Huang WW; Peng SF; Chung JG
Anticancer Res; 2016 Nov; 36(11):6031-6042. PubMed ID: 27793930
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of cancer stem cell therapy.
Akbar Samadani A; Keymoradzdeh A; Shams S; Soleymanpour A; Elham Norollahi S; Vahidi S; Rashidy-Pour A; Ashraf A; Mirzajani E; Khanaki K; Rahbar Taramsari M; Samimian S; Najafzadeh A
Clin Chim Acta; 2020 Nov; 510():581-592. PubMed ID: 32791136
[TBL] [Abstract][Full Text] [Related]
34. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
[TBL] [Abstract][Full Text] [Related]
35. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
[TBL] [Abstract][Full Text] [Related]
36. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.
Kok SH; Cheng SJ; Hong CY; Lee JJ; Lin SK; Kuo YS; Chiang CP; Kuo MY
Cancer Lett; 2005 Jan; 217(1):43-52. PubMed ID: 15596295
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.
Das PK; Islam F; Smith RA; Lam AK
Front Oncol; 2020; 10():598957. PubMed ID: 33665161
[TBL] [Abstract][Full Text] [Related]
38. Cantharidin impairs cell migration and invasion of A375.S2 human melanoma cells by suppressing MMP-2 and -9 through PI3K/NF-κB signaling pathways.
Ji BC; Hsiao YP; Tsai CH; Chang SJ; Hsu SC; Liu HC; Huang YP; Lien JC; Chung JG
Anticancer Res; 2015 Feb; 35(2):729-38. PubMed ID: 25667452
[TBL] [Abstract][Full Text] [Related]
39. Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells.
Lee YC; Lee LM; Yang CH; Lin AM; Huang YC; Hsu CC; Chen MS; Chi CW; Yin PH; Kuo CD; Liao JF; Lee HC
Oncol Rep; 2013 Jan; 29(1):237-43. PubMed ID: 23128522
[TBL] [Abstract][Full Text] [Related]
40. Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment.
Koury J; Zhong L; Hao J
Stem Cells Int; 2017; 2017():2925869. PubMed ID: 28356914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]